The present disclosure generally relates to a multifunctional additive obtained from the reaction of: (a) an intermediate obtained from the reaction of maleic anhydride and a polyoxyalkylene monoamine; and (b) an amine compound comprising a primary amine group and/or a secondary amine group and its use in a variety of applications, including, but not limited to: as a corrosion inhibitor or friction modifier in aqueous and non-aqueous systems; in fuel deposit control agents; as a dispersant in pigment, asphalt and cement compositions; and as a detergent.

The present invention provides a raw material for bulk drugs and a pharmaceutical additive which provide excellent formulation stability and excellent over-time stability of drug efficacy when used to modify a bulk drug, a polypeptide, a bioactive protein, an enzyme, and the like. The present invention relates to a raw material for bulk drugs or a pharmaceutical additive, containing: a polyether composition (A) represented by formula (1), wherein the polyether composition (A) has a unimodal molecular weight distribution, the polyether composition (A) has a ratio (Mw/Mn) of the weight average molecular weight (Mw) to the number average molecular weight (Mn) of 1.20 or less, and the polyether composition (A) contains a compound in which m is 1 in formula (1) in an amount of 90 wt % or more based on the weight of the polyether composition (A), in formula (1), OR.sup.1, R.sup.2O, R.sup.3O, and R.sup.4O are each independently a C2-C8 oxyalkylene group; when each of these moieties exists in the plural number, each OR.sup.1, each R.sup.2O, each R.sup.3O, and each R.sup.4O may be the same as or different from each other; these moieties may be bonded randomly or in block; a, b, c, and d are each independently an integer of 50 to 1200; X.sup.1 to X.sup.4 are each independently a hydrogen atom, a substituent represented by formula (2), or a substituent represented by formula (3); and m is an integer of 1 to 10.

##STR00001##

The present disclosure provides for a metal chelated polyol liquid and/or a metal chelated polyether polyol liquid that can be used in an isocyanate-reactive composition and a reaction mixture for forming a polyurethane polymer. The metal chelated polyester polyol liquid is a reaction product of a chelating polyester polyol having a chelating moiety and a metal compound having a metal ion. The metal chelated polyether polyol liquid is a reaction product of a chelating polyether polyol having a chelating moiety and a metal compound having a metal ion. The chelating moiety of the chelating polyester polyol or the chelating polyether polyol chelates the metal ion to form the metal chelated polyester polyol liquid or the metal chelated polyether polyol liquid, respectively, having a mole ratio of the metal ion to the chelating moiety of 0.05:1 to 2:1.

The present invention relates to a biocompatible hydrogel comprising hyaluronic acid and polyethylene glycol, and more particularly, to a biocompatible hydrogel prepared by inducing inter-molecular and/or intra-molecular cross-linking of hyaluronic acid and polyethylene glycol only by irradiating radiation without adding a reactor, a chemical cross-linking agent, or the like, a method for preparing the same, and the use thereof.

Disclosed are a novel monofunctional polyethylene glycol (PEG) and derivatives thereof. More particularly, one terminal of each of the monofunctional polyethylene glycol and derivatives thereof is modified with a siloxy group. The novel monofunctional polyethylene glycol (PEG) offers an alternative to methoxy polyethylene glycol.

The present invention provides a raw material for bulk drugs and a pharmaceutical additive which provide excellent formulation stability and excellent over-time stability of drug efficacy when used to modify a bulk drug, a polypeptide, a bioactive protein, an enzyme, and the like. The present invention relates to a raw material for bulk drugs or a pharmaceutical additive, containing: a polyether composition (A) represented by formula (1), wherein the polyether composition (A) has a unimodal molecular weight distribution, the polyether composition (A) has a ratio (Mw/Mn) of the weight average molecular weight (Mw) to the number average molecular weight (Mn) of 1.20 or less, and the polyether composition (A) contains a compound in which m is 1 in formula (1) in an amount of 90 wt % or more based on the weight of the polyether composition (A), in formula (1), OR.sup.1, R.sup.2O, R.sup.3O, and R.sup.4O are each independently a C2-C8 oxyalkylene group; when each of these moieties exists in the plural number, each OR.sup.1, each R.sup.2O, each R.sup.3O, and each R.sup.4O may be the same as or different from each other; these moieties may be bonded randomly or in block; a, b, c, and d are each independently an integer of 50 to 1200; X.sup.1 to X.sup.4 are each independently a hydrogen atom, a substituent represented by formula (2), or a substituent represented by formula (3); and m is an integer of 1 to 10. ##STR00001##

A crosslinkable composition comprising: A) at least one polymerisable monomer or a mixture of polymerisable monomers or a mixture of polymerisable monomers and macromonomers bearing at least one polymerisable C═C function of the acrylate, methacrylate, maleate, fumarate, itaconate, citraconate, styrene or vinyl type; B) at least one polyol chosen from oligoglycerols, linear, branched and hyperbranched polyglycerols, or a mixture of hyperbranched polyglycerol and a polyol chosen from oligoglycerols, and linear, branched and hyperbranched polyglycerols, comprising, on average, more than 1 hydroxyl group functionalised with a group bearing a polymerisable C═C function of the acrylate, methacrylate, maleate, fumarate, itaconate, citraconate, styrene or vinyl type; C) a free radical initiator or a mixture of free radical initiators capable of initiating polymerisation by thermal, redox or photochemical means; and D) optionally, at least one additive.

Described herein is a method for producing a coating system on a substrate, including producing a cured basecoat film on the substrate by applying a pigmented aqueous basecoat material to the substrate and subsequently curing the basecoat material, wherein the basecoat material includes a polyether-based reaction product which is preparable by reaction of (a) at least one cyclic tetracarboxylic dianhydride having an aliphatic, aromatic or araliphatic radical X which bridges the two anhydride groups,
with (b) at least one polyether of a general structural formula (II) ##STR00001##
in which R is a C.sub.3 to C.sub.6 alkylene radical and n is selected such that the polyether (b) possesses a number-average molecular weight of 500 to 5000 g/mol, and wherein components (a) and (b) are used in the reaction in a molar ratio of 0.7/2.3 to 1.6/1.7 and a resulting reaction product possesses an acid number of 5 to 80 mg KOH/g.

This disclosure relates to polymersomes comprising a crosslinked polymer and their use as drug delivery vehicles. Specifically, polymersomes comprising a polymer of Formula I: ##STR00001##
wherein each R is independently C.sub.1-6 alkyl; and n is an integer between 1 and 50.

Disclosed herein are ionic polymers incorporating an cationic atom in the polymer backbone.